Marianne De Backer
President, CEO & DirectorDr. Marianne De Backer, MSc, Ph. D. MBA, is a CEO & Director of Vir Biotechnology, Inc., since April 03, 2023 and also serves as its President from March 4, 2026. She served as Independent Director at Kronos Bio, Inc. from January 25, 2021 to June 2023. Dr. De Backer served as Executive Vice President, Head of Global Business Development and Licensing and a Member of the Executive dep. of the Pharmaceuticals Division of Bayer AG. Before joining Bayer, she held a series of positions in the Johnson & Johnson family of companies. She started as a scientist and scientific group leader during which time her work resulted in multiple patents. She progressed through commercial positions internationally including leading a sales and marketing business unit responsible for several product lines, culminating as Vice President, M&A Operations, Divestitures and Janssen Business Development. During her tenure with Johnson & Johnson, she had direct accountability for several strategic alliances. She served on the Board of Directors of ArrowHead Pharmaceuticals until April 02, 2023. She currently serves as a Non-Executive Director on the Boards of Directors of the Gladstone Foundation and serves on the Boards of Bayer companies: Vividion Therapeutics, Inc. and BlueRock Therapeutics LP. She served as a Director at Asklepios BioPharmaceutical, Inc. until January 2023. She has broad international leadership past work, including a strong track record in global expansion, innovation technology licensing and multiple mergers and acquisitions. Throughout her career, she has been directly accountable for more than 200 strategic alliances in healthcare, many of which have led to approved medicines now available to patients. She received a MSc in Molecular Biology from Vrije Universiteit Brussel and from the University of Brussels, Belgium, a master’s in engineering and Biochemistry and a Ph. D. in Biotechnology from the University of Ghent, Belgium and an MBA from Rotterdam School of Management, Erasmus University, the Netherlands.
Positions
- Company NameVir Biotechnology, Inc.Stock CodeVIRPositionPresident, CEO & DirectorColleagues
